Automated lipid nanoparticle production could accelerate the development of RNA therapies
RNA vaccines and other nucleic acid therapeutics are typically packaged within fatty molecules known as lipid nanoparticles (LNPs). MIT researchers have now developed a way to produce these particles much more quickly and with more precise control over their size and shape.
- Published by
- Phys.org
- Evidence type
- Laboratory
RNA vaccines and other nucleic acid therapeutics are typically packaged within fatty molecules known as lipid nanoparticles (LNPs). MIT researchers have now developed a way to produce these particles much more quickly and with more precise control over their size and shape.
This item was selected automatically by our daily literature and news monitor because it matches the topics we follow. Read the full story at Phys.org.
Let's engineer the next delivery breakthrough together
We co-develop nanocarrier and biosensing programmes with pharma, biotech and academic groups — from target selection through scale-up.